Influence of Nitric Oxide Synthase and Adrenergic Inhibition on Adenosine-Induced Myocardial Hyperemia
暂无分享,去创建一个
M. Mulvany | N. Buus | F. Hermansen | T. Nielsen | M. Bøttcher | M. Sander
[1] Y. Hellsten,et al. Exercise‐induced hyperaemia and leg oxygen uptake are not altered during effective inhibition of nitric oxide synthase with NG‐nitro‐l‐arginine methyl ester in humans , 2001, The Journal of physiology.
[2] G. D. Thomas,et al. Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[3] I. Meredith,et al. Contribution of vasodilator prostanoids and nitric oxide to resting flow, metabolic vasodilation, and flow-mediated dilation in human coronary circulation. , 1999, Circulation.
[4] L. Kuo,et al. Adenosine A2A Receptors Mediate Coronary Microvascular Dilation to Adenosine: Role of Nitric Oxide and ATP-Sensitive Potassium Channels , 1999 .
[5] J. Viikari,et al. Coronary flow reserve in young men with familial combined hyperlipidemia. , 1999, Circulation.
[6] R. Victor,et al. A large blood pressure-raising effect of nitric oxide synthase inhibition in humans. , 1999, Hypertension.
[7] M. Mulvany,et al. Reduced vasodilator capacity in syndrome X related to structure and function of resistance arteries. , 1999, The American journal of cardiology.
[8] J. Viikari,et al. Early impairment of coronary flow reserve in young men with borderline hypertension. , 1998, Journal of the American College of Cardiology.
[9] I. Biaggioni,et al. Role of nitric oxide in adenosine-induced vasodilation in humans. , 1998, Hypertension.
[10] B. Strauer,et al. Alterations of the architecture of subendocardial arterioles in patients with hypertrophic cardiomyopathy and impaired coronary vasodilator reserve: a possible cause for myocardial ischemia. , 1998, Journal of the American College of Cardiology.
[11] F. Klocke,et al. Coronary vascular responsiveness to adenosine is impaired additively by blockade of nitric oxide synthesis and a sulfonylurea. , 1998, Journal of the American College of Cardiology.
[12] T. Lehtimäki,et al. Coronary Flow Reserve Is Reduced in Young Men With IDDM , 1998, Diabetes.
[13] Y Nishikawa,et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. , 1997, Circulation.
[14] D. Neglia,et al. Comparative effects of enalapril and verapamil on myocardial blood flow in systemic hypertension. , 1997, Circulation.
[15] R. Bache,et al. Endogenous nitric oxide masks alpha 2-adrenergic coronary vasoconstriction during exercise in the ischemic heart. , 1997, Circulation research.
[16] S. Ando,et al. Comparison of hemodynamic and sympathoneural responses to adenosine and lower body negative pressure in man. , 1997, Canadian journal of physiology and pharmacology.
[17] M. Phelps,et al. Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] P. Camici,et al. Effect of alpha 1-adrenoceptor blockade on resting and hyperemic myocardial blood flow in normal humans. , 1996, The American journal of physiology.
[19] M. Creager,et al. Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. , 1996, Hypertension.
[20] G. Kajiyama,et al. Flow-mediated vasodilation of human epicardial coronary arteries: effect of inhibition of nitric oxide synthesis. , 1996, Journal of the American College of Cardiology.
[21] R. Ator,et al. Modulation of coronary flow by left ventricular volume in the presence and absence of vasomotor tone. , 1995, The American journal of physiology.
[22] M. Creager,et al. Endothelial release of nitric oxide contributes to the vasodilator effect of adenosine in humans. , 1995, Circulation.
[23] A. Quyyumi,et al. Contribution of nitric oxide to metabolic coronary vasodilation in the human heart. , 1995, Circulation.
[24] A. Nitenberg,et al. Coronary artery constriction caused by the cold pressor test in human hypertension. , 1994, Hypertension.
[25] P. Camici,et al. Relation between myocardial blood flow and the severity of coronary-artery stenosis. , 1994, The New England journal of medicine.
[26] I. Biaggioni,et al. Adenosine activates afferent fibers in the forearm, producing sympathetic stimulation in humans. , 1993, The Journal of pharmacology and experimental therapeutics.
[27] M. Phelps,et al. Influence of Age and Hemodynamics on Myocardial Blood Flow and Flow Reserve , 1993, Circulation.
[28] William M. Chilian,et al. Endothelium‐Dependent Relaxation Competes With &agr;1‐ and &agr;2‐Adrenergic Constriction in the Canine Epicardial Coronary Microcirculation , 1993, Circulation.
[29] M. Winniford,et al. Effect of increases in heart rate and arterial pressure on coronary flow reserve in humans. , 1993, Journal of the American College of Cardiology.
[30] S S Gambhir,et al. Quantification of Regional Myocardial Blood Flow Using 13N‐Ammonia and Reoriented Dynamic Positron Emission Tomographic Imaging , 1992, Circulation.
[31] P. Ganz,et al. Patients With Evidence of Coronary Endothelial Dysfunction as Assessed by Acetylcholine Infusion Demonstrate Marked Increase in Sensitivit to Constrictor Effects of Catecholamines , 1992, Circulation.
[32] W. Chilian. Functional distribution of alpha 1- and alpha 2-adrenergic receptors in the coronary microcirculation. , 1991, Circulation.
[33] W. Chilian. Functional Distribution of α1‐ and α2‐Adrenergic Receptors in the Coronary Microcirculation , 1991 .
[34] R. Wilson,et al. Interstudy variability of coronary flow reserve. Influence of heart rate, arterial pressure, and ventricular preload. , 1990, Circulation.
[35] M E Phelps,et al. 13N ammonia myocardial imaging at rest and with exercise in normal volunteers. Quantification of absolute myocardial perfusion with dynamic positron emission tomography. , 1989, Circulation.